Cargando…

Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women

BACKGROUND: Human papillomavirus (HPV) has been found as the most considerable causes of cervical cancer. Recently, several molecular methods have been introduced to increase the accuracy of the screening programs and decrease the mortality rate. Among these methods, mRNA-based methods have more adv...

Descripción completa

Detalles Bibliográficos
Autores principales: MOUSAVI, Azam-Sadat, POURYASIN, Ali, YARANDI, Fariba, PIRZADEH, Leila, ALIPOUR, Abbas, KHODADAD, Shakiba, POURYASIN, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898099/
https://www.ncbi.nlm.nih.gov/pubmed/33643949
http://dx.doi.org/10.18502/ijph.v49i9.4093
_version_ 1783653801864986624
author MOUSAVI, Azam-Sadat
POURYASIN, Ali
YARANDI, Fariba
PIRZADEH, Leila
ALIPOUR, Abbas
KHODADAD, Shakiba
POURYASIN, Mohammad
author_facet MOUSAVI, Azam-Sadat
POURYASIN, Ali
YARANDI, Fariba
PIRZADEH, Leila
ALIPOUR, Abbas
KHODADAD, Shakiba
POURYASIN, Mohammad
author_sort MOUSAVI, Azam-Sadat
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) has been found as the most considerable causes of cervical cancer. Recently, several molecular methods have been introduced to increase the accuracy of the screening programs and decrease the mortality rate. Among these methods, mRNA-based methods have more advantages as they assess the expression level of HPV E6 and E7 oncogenic mRNAs. This study aimed to evaluate the results of HPV RNA- and DNA-based methods among Iranian women population with normal cytology results. METHODS: Overall, 4640 women were enrolled referred to the Gynecology Oncology Ward of Vali-e-Asr Hospital, private and academic clinics, Tehran, Iran from Jan 2016 to Apr 2018. To assess the HPV-DNA infection INNO-LiPA® HPV Genotyping Extra-II kit was used. For HPV-RNA assessment, Aptima HPV Assay and in house HPV-RNA genotyping methods were applied. RESULTS: The positivity rates of HPV infection according to DNA- and RNA-based methods were 18.0% and 11.2%, respectively (P<0.001). The positive predictive value, negative predictive value, specificity and sensitivity of DNA-based method in contrast with RNA-based method were 59.2% (56.6–61.6), 99.4% (99.0–99.6), 91.7% (90.8–92.6) and 95.2% (93.0–96.9) respectively. CONCLUSION: At the present study for prognosis of cervical cancer, RNA-based method seemed to be more specific in contrast to DNA-based method. Patient follow up and further studies will be conducted in order to clarify the clinical sensitivity and specificity of the two methods.
format Online
Article
Text
id pubmed-7898099
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-78980992021-02-25 Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women MOUSAVI, Azam-Sadat POURYASIN, Ali YARANDI, Fariba PIRZADEH, Leila ALIPOUR, Abbas KHODADAD, Shakiba POURYASIN, Mohammad Iran J Public Health Original Article BACKGROUND: Human papillomavirus (HPV) has been found as the most considerable causes of cervical cancer. Recently, several molecular methods have been introduced to increase the accuracy of the screening programs and decrease the mortality rate. Among these methods, mRNA-based methods have more advantages as they assess the expression level of HPV E6 and E7 oncogenic mRNAs. This study aimed to evaluate the results of HPV RNA- and DNA-based methods among Iranian women population with normal cytology results. METHODS: Overall, 4640 women were enrolled referred to the Gynecology Oncology Ward of Vali-e-Asr Hospital, private and academic clinics, Tehran, Iran from Jan 2016 to Apr 2018. To assess the HPV-DNA infection INNO-LiPA® HPV Genotyping Extra-II kit was used. For HPV-RNA assessment, Aptima HPV Assay and in house HPV-RNA genotyping methods were applied. RESULTS: The positivity rates of HPV infection according to DNA- and RNA-based methods were 18.0% and 11.2%, respectively (P<0.001). The positive predictive value, negative predictive value, specificity and sensitivity of DNA-based method in contrast with RNA-based method were 59.2% (56.6–61.6), 99.4% (99.0–99.6), 91.7% (90.8–92.6) and 95.2% (93.0–96.9) respectively. CONCLUSION: At the present study for prognosis of cervical cancer, RNA-based method seemed to be more specific in contrast to DNA-based method. Patient follow up and further studies will be conducted in order to clarify the clinical sensitivity and specificity of the two methods. Tehran University of Medical Sciences 2020-09 /pmc/articles/PMC7898099/ /pubmed/33643949 http://dx.doi.org/10.18502/ijph.v49i9.4093 Text en Copyright © 2020 Mousavi et al. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
MOUSAVI, Azam-Sadat
POURYASIN, Ali
YARANDI, Fariba
PIRZADEH, Leila
ALIPOUR, Abbas
KHODADAD, Shakiba
POURYASIN, Mohammad
Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
title Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
title_full Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
title_fullStr Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
title_full_unstemmed Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
title_short Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
title_sort assessment of cervical cancer molecular-based screening tools; hpv-dna detection versus e6/e7 mrna testing; first report of a prospective cohort study among iranian women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898099/
https://www.ncbi.nlm.nih.gov/pubmed/33643949
http://dx.doi.org/10.18502/ijph.v49i9.4093
work_keys_str_mv AT mousaviazamsadat assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen
AT pouryasinali assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen
AT yarandifariba assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen
AT pirzadehleila assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen
AT alipourabbas assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen
AT khodadadshakiba assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen
AT pouryasinmohammad assessmentofcervicalcancermolecularbasedscreeningtoolshpvdnadetectionversuse6e7mrnatestingfirstreportofaprospectivecohortstudyamongiranianwomen